Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors.

Author: HarrodTom, HdeibAlia, LiYiping, LoSimon S, OlsonJeffrey J, RykenTimothy, ShermanJonathan H

Paper Details 
Original Abstract of the Article :
QUESTION 1: Should patients with brain metastases receive chemotherapy in addition to whole brain radiotherapy (WBRT) for the treatment of their brain metastases? TARGET POPULATION: This recommendation applies to adult patients with newly diagnosed brain metastases amenable to both chemotherapy and...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/neuros/nyy544

データ提供:米国国立医学図書館(NLM)

Navigating the Complexities of Treating Metastatic Brain Tumors

Metastatic brain tumors, a serious complication of cancer that occurs when cancer cells spread to the brain, present a significant challenge for doctors and patients alike. This study provides evidence-based guidelines on the role of chemotherapy in the management of newly diagnosed metastatic brain tumors.

The guidelines address three key questions: whether chemotherapy should be used in addition to whole brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS), and whether chemotherapy alone is effective. The study found that routine use of chemotherapy following WBRT is not recommended, while routine use of WBRT plus temozolomide is recommended for patients with triple-negative breast cancer. For patients receiving SRS, chemotherapy is not routinely recommended, but may be considered in combination with SRS for patients with lung adenocarcinoma. The study concluded that routine use of cytotoxic chemotherapy alone is not recommended for metastatic brain tumors, as it has not been shown to increase overall survival.

Understanding the Limitations of Chemotherapy

The guidelines highlight the need for a careful and individualized approach to treating metastatic brain tumors, acknowledging the limitations of chemotherapy in this context.

The Importance of Multidisciplinary Care

The study emphasizes the importance of multidisciplinary care, involving a team of specialists, to develop the most effective treatment plan for each patient.

Dr.Camel's Conclusion

Navigating the complex terrain of metastatic brain tumor treatment requires a thorough understanding of the strengths and limitations of different treatment modalities. This study provides a valuable guide for doctors and patients, reminding us that the journey towards effective treatment often involves a multidisciplinary approach and a careful consideration of individual factors.

Date :
  1. Date Completed 2019-12-31
  2. Date Revised 2019-12-31
Further Info :

Pubmed ID

30629221

DOI: Digital Object Identifier

10.1093/neuros/nyy544

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.